Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic abnormalities in HIV infection.

K M Zunich1, H C Lane

  • 1Transplantation Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

Hematology/Oncology Clinics of North America
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of an antibody to α<sub>4</sub>β<sub>7</sub> in the control of SIVmac239-<i>nef-stop</i> infection.

Science (New York, N.Y.)·2019
Same author

CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodies.

PloS one·2017
Same author

Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection.

Clinical immunology (Orlando, Fla.)·2015
Same author

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

HIV medicine·2014
Same author

HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?

HIV medicine·2013
Same author

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.

The Journal of antimicrobial chemotherapy·2013
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

HIV infection progressively impairs immune function by depleting CD4+ T lymphocytes, crucial for host defense. Understanding these immunologic defects is key to developing better HIV therapies.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus (HIV) infection is characterized by a progressive decline in CD4+ T lymphocytes.
  • CD4+ T cells are central to immune responses, orchestrating functions of CD8+ T cells, B lymphocytes, NK cells, and macrophages.

Purpose of the Study:

  • To elucidate the immunologic defects in HIV infection.
  • To provide a basis for developing improved therapeutic strategies against HIV.

Main Methods:

  • The study focuses on the characteristic immunologic abnormalities in HIV infection.
  • It reviews the impact of CD4+ T cell depletion on various immune cell functions.
  • Analysis includes immune responses occurring prior to detectable CD4+ cell loss.

Related Experiment Videos

Main Results:

  • Progressive decline in CD4+ T lymphocyte number and function is a hallmark of HIV infection.
  • Loss of CD4+ T cells impairs multiple immune functions, including CD8+ T cell, B cell, NK cell, and monocyte/macrophage activity.
  • Immunologic abnormalities, such as impaired responses to antigens, can precede detectable CD4+ T cell depletion.

Conclusions:

  • CD4+ T cell depletion is a major factor in HIV pathogenesis.
  • Understanding the precise nature of HIV-induced immunologic defects is essential for advancing therapeutic interventions.